Cargando…

Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes

The 5-year survival rate of early gastric cancer (EGC) is significantly higher compared with that of advanced gastric cancer; however, the general diagnostic rate of EGC remains low in certain regions. The discovery of novel methods for diagnosing EGC will be beneficial for the general population. A...

Descripción completa

Detalles Bibliográficos
Autor principal: Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576993/
https://www.ncbi.nlm.nih.gov/pubmed/33101489
http://dx.doi.org/10.3892/ol.2020.12158
_version_ 1783598123648548864
author Zhang, Hao
author_facet Zhang, Hao
author_sort Zhang, Hao
collection PubMed
description The 5-year survival rate of early gastric cancer (EGC) is significantly higher compared with that of advanced gastric cancer; however, the general diagnostic rate of EGC remains low in certain regions. The discovery of novel methods for diagnosing EGC will be beneficial for the general population. Among all gastric cancers, ~90% are sporadic, 10% are characterized as familial aggregation, and 3–5% of gastric cancer is attributed to genetic predisposition. Compared with sporadic cancer types, hereditary cancer syndromes (HCS) are usually characterized by the development of cancer at an early age. The present study proposes an approach for promoting the diagnostic rate of EGC in the general population by managing individuals with a family history of HCS and germline mutations of susceptibility genes. The proposed management strategy has three steps: i) Establish family history archives of the general population to screen families with individuals who have HCS; ii) recommend genetic testing for the individuals among the selected families to screen for high-risk EGC, (i.e., with HCS family history and genetic mutations); and iii) perform active routine surveillance for selected individuals to improve the overall diagnostic rate of EGC in the general population. Individuals with a positive family history should undergo the process presented above early in life, while those with a negative history may undergo routine inspection when necessary. With advances in the medical field and reductions in the cost of genetic testing, the diagnostic rate of EGC may be improved.
format Online
Article
Text
id pubmed-7576993
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-75769932020-10-22 Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes Zhang, Hao Oncol Lett Review The 5-year survival rate of early gastric cancer (EGC) is significantly higher compared with that of advanced gastric cancer; however, the general diagnostic rate of EGC remains low in certain regions. The discovery of novel methods for diagnosing EGC will be beneficial for the general population. Among all gastric cancers, ~90% are sporadic, 10% are characterized as familial aggregation, and 3–5% of gastric cancer is attributed to genetic predisposition. Compared with sporadic cancer types, hereditary cancer syndromes (HCS) are usually characterized by the development of cancer at an early age. The present study proposes an approach for promoting the diagnostic rate of EGC in the general population by managing individuals with a family history of HCS and germline mutations of susceptibility genes. The proposed management strategy has three steps: i) Establish family history archives of the general population to screen families with individuals who have HCS; ii) recommend genetic testing for the individuals among the selected families to screen for high-risk EGC, (i.e., with HCS family history and genetic mutations); and iii) perform active routine surveillance for selected individuals to improve the overall diagnostic rate of EGC in the general population. Individuals with a positive family history should undergo the process presented above early in life, while those with a negative history may undergo routine inspection when necessary. With advances in the medical field and reductions in the cost of genetic testing, the diagnostic rate of EGC may be improved. D.A. Spandidos 2020-12 2020-09-25 /pmc/articles/PMC7576993/ /pubmed/33101489 http://dx.doi.org/10.3892/ol.2020.12158 Text en Copyright: © Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Zhang, Hao
Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes
title Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes
title_full Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes
title_fullStr Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes
title_full_unstemmed Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes
title_short Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes
title_sort improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576993/
https://www.ncbi.nlm.nih.gov/pubmed/33101489
http://dx.doi.org/10.3892/ol.2020.12158
work_keys_str_mv AT zhanghao improvingtheoveralldiagnosticrateofearlygastriccancerbymanagingfamilymemberswithhereditarycancersyndromes